AMGN vs ERNA · P/E 24, rev $36.75B vs P/E 0.0, rev $582.0K
Amgen Inc (AMGN) versus Eterna Therapeutics Inc (ERNA) — a side-by-side from cached financials, not a winner call.
Amgen Inc (AMGN) is a drug manufacturers - general company listed on US.
Eterna Therapeutics Inc (ERNA) is a biotechnology company listed on NASDAQ.
Latest reported AMGN revenue for 2025-12-31 was $36.75B. Net income was $7.71B. Revenue was up 10.0% from 2024-12-31 to 2025-12-31. AMGN currently screens at market cap $188.67B and trailing P/E 24.3.
Latest reported ERNA revenue for 2024-12-31 was $582.0K. Net income was -$44.5M. Revenue was up 755.9% from 2023-12-31 to 2024-12-31. ERNA currently screens at market cap $6.9M and trailing P/E 0.0.
AMGN currently screens at market cap $188.67B and trailing P/E 24.3. ERNA currently screens at market cap $6.9M and trailing P/E 0.0.
Not investment advice. Open the AMGN and ERNA stock pages for the full models.
Not investment advice.